MCM
INSM icon

Manchester Capital Management’s Insmed INSM Stock Holding History

Manchester Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
1,033
+16
+2% +$1.94K 0.01% 374
2026
Q1 		$166K Sell
1,017
-3
-0.3% -$461 0.02% 293
2025
Q4 		$178K Hold
1,020
– – 0.02% 286
2025
Q3 		$147K Buy
1,020
+16
+2% +$1.96K 0.02% 360
2025
Q2 		$101K Buy
+1,004
New +$76.8K 0.01% 446
2021
Q3 		– Sell
-29
Closed -$1K – 1083
2021
Q2 		$1K Buy
+29
New +$861 ﹤0.01% 754

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Manchester Capital Management's INSM Position: Q2 2026 in Review

Manchester Capital Management increased its Insmed (INSM) stake by 1.6% in Q2 2026, buying an estimated $1.94K and bringing the position to 1,033 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #374.

Manchester Capital Management first reported a position in INSM in Q2 2021 and has held it in 6 quarters since. The position peaked at $178K in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Manchester Capital Management held 1,033 shares of Insmed worth $110K as of Q2 2026.
  • Manchester Capital Management bought 16 Insmed shares in Q2 2026, an estimated $1.94K.
  • Insmed made up 0.01% of Manchester Capital Management's portfolio in Q2 2026, its #374 holding.
  • Manchester Capital Management first reported a position in Insmed in Q2 2021 and has held it in 6 quarters since.
  • Manchester Capital Management's Insmed position peaked at $178K in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.